The - 1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 4, 2008, Pages 485-490

  Kieling, Christian ^a   Genro, Julia P ^a   Hutz, Mara H ^a   Rohde, Luis Augusto ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Attention deficit hyperactivity disorder; Dopamine hydroxylase; Endophenotype; Executive functions

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CATECHOLAMINERGIC SYSTEM; CHILD; ENZYME ACTIVITY; FEMALE; GENETIC REGULATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; TASK PERFORMANCE; WISCONSIN CARD SORTING TEST;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COGNITION; DOPAMINE BETA-HYDROXYLASE; GENOTYPE; HUMANS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 45149118397     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30636     Document Type: Article

References (60)

1. American Psychiatric Association. 1994. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington DC: American Psychiatric Association. 886 p.
2. Arnsten AF, Li BM. 2005. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384.
3. Aston-Jones G, Cohen JD. 2005. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu Rev Neurosci 28:403-450.
4. Barkley RA, Smith KM, Fischer M, Navia B. 2006. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet Part B 141B:487-498.
5. Bellgrove MA, Hawi Z, Gill M, Robertson IH. 2006a. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotype. Cortex 42:838-845.
6. Bellgrove MA, Mattingley JB, Hawi Z, et al. 2006b. Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder. Biol Psychiatry 60:1039-1045.
7. Berg EA. 1948. A simple objective technique for measuring flexibility in thinking. J Gen Psychol 39:15-22.
8. Bhaduri N, Mukhopadhyay K. 2006. Lack of significant association between -1021C- >T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci Lett 402:12-16.
9. Biederman J, Monuteaux MC, Doyle AE, et al. 2004. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 72:757-766.
10. Biederman J, Petty C, Fried R, et al. 2006. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 163:1730-1738.
11. Bourdelat-Parks BN, Anderson GM, Donaldson ZR, et al. 2005. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 183:72-80.
12. Conners CK. 1985. The Computerized Continuous Performance-Test. Psychopharmacol Bull 21:891-892.
13. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyerkimling L. 1988. The Continuous Performance-Test, Identical Pairs Version (CPT-IP). 1. New findings about sustained attention in normal-families. Psychiatry Res 26:223-238.
14. Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. 1988. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48:48-50.
15. Cubells JF, Zabetian CP. 2004. Human genetics of plasma dopamine beta-hydroxylase activity: Applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174:463-476.
16. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192-196.
17. Devoto P, Flore G, Pani L, Gessa GL. 2001. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-664.
18. Doyle AE, Willcutt EG, Seidman LJ, et al. 2005. Attention-deficit/ hyperactivity disorder endophenotypes. Biol Psychiatry 57:1324-1335.
19. Faraone SV, Perlis RH, Doyle AE, et al. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
20. Frank MJ, Santamaria A, O'Reilly RC, Willcutt E. 2007. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32:1583-1599.
21. Freedman LS, Ohuchi T, Goldstein M, Axelrod F, Fish I, Dancis J. 1972. Changes in human serum dopamine-beta-hydroxylase activity with age. Nature 236:310-311.
22. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP. 1989. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249-271.
23. Hair JF, Tatham RL, Anderson RE, Black W. 1998. Multivariate data analysis. Upper Saddle River: Prentice Hall. 768 p.
24. Jonsson EG, Bah J, Melke J, et al. 2004. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry 4:4.
25. Köhnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, Buchkremer G, Vonthein. 2002. A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 52:1151-1158.
26. Koren D, Seidman LJ, Harrison RH, et al. 1998. Factor structure of the Wisconsin Card Sorting Test: Dimensions of deficit in schizophrenia. Neuropsychology 12:289-302.
27. Laird NM, Lange C. 2006. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet 7:385-394.
28. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. 2004. PBAT: Tools for family-based association studies. Am J Hum Genet 74:367-369.
29. Lawrence V, Houghton S, Douglas G, Durkin K, Whiting K, Tannock R. 2004. Executive function and ADHD: A comparison of children's performance during neuropsychological testing and real-world activities. J Atten Disord 7:137-149.
30. Maldonado G, Greenland S. 1993. Simulation study of confounder-selection strategies. Am J Epidemiol 138:923-936.
31. Montague PR, Hyman SE, Cohen JD. 2004. Computational roles for dopamine in behavioural control. Nature 431:760-767.
32. Montgomery DC. 1997. Design and analysis of experiments. New York: Wiley. 720 p.
33. Nigg JT. 2005. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: The state of the field and salient challenges for the coming decade. Biol Psychiatry 57:1424-1435.
34. Nigg JT, Blaskey LG, Stawicki JA, Sachek J. 2004. Evaluating the endophenotype model of ADHD neuropsychological deficit: Results for parents and siblings of children with ADHD combined and inattentive subtypes. J Abnorm Psychol 113:614-625.
35. Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJ. 2005. Causal heterogeneity in attention-deficit/hyperactivity disorder: Do we need neuropsychologically impaired subtypes? Biol Psychiatry 57:1224-1230.
36. Oades RD, Sadile AG, Sagvolden T, et al. 2005. The control of responsiveness in ADHD by catecholamines: Evidence for dopaminergic, noradrenergic and interactive roles. Dev Sci 8:122-131.
37. Orvaschel H. 1985. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull 21:737-745.
38. Paclt I, Koudelova J. 2004. Changes of dopamine-beta-hydroxylase activity during ontogenesis in healthy subjects and in an experimental model (rats). Physiol Res 53:661-667.
39. Parasuraman R, Greenwood PM, Kumar R, Fossella J. 2005. Beyond heritability - Neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychol Sci 16:200-207.
40. Pennington BF. 2005. Toward a new neuropsychological model of attention-deficit/hyperactivity disorder: Subtypes and multiple deficits. Biol Psychiatry 57:1221-1223.
41. Pliszka SR. 2005. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57:1385-1390.
42. Rohde LA. 2002. ADHD in Brazil: The DSM-IV criteria in a culturally different population. J Am Acad Child Adolesc Psychiatry 41:1131-1133.
43. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. 2002. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114:154-158.
44. Russell VA. 2002. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res 130:191-196.
45. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. 2005. Rodent models of attention-dencit/hyperactivity disorder. Biol Psychiatry 57:1239-1247.
46. Sergeant J. 2005a. Are we ready for endophenotypes in attention deficit hyperactivity disorder? Rev Bras Psiquiatr 27:262-263.
47. Sergeant J. 2005b. Modeling attention-dencit/hyperactivity disorder: A critical appraisal of the cognitive-energetic model. Biol Psychiatry 57:1248-1255.
48. Sonuga-Barke EJ. 2005. Causal models of attention-dencit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231-1238.
49. Swanson JM, Kraemer HC, Hinshaw SP, et al. 2001. Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168-179.
50. Tang YL, Buxbaum SG, Waldman I, et al. 2006. A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 60:1034-1038.
51. Togsverd M, Werge TM, Tankó LB, Bagger YZ, Qin GG, Hansen T, Christiansen C, Rasmussen HB. 2007. Cognitive performance in elderly women: Significance of the 19bp insertion/deletion polymorphism in the 5′ flank of the dopamine beta-hydroxylase gene, educational level, body fat measures, serum triglyceride, alcohol consumption and age. Int J Geriatr Psychiatry 22(9):883-889.
52. Waldman ID. 2005. Statistical approaches to complex phenotypes: Evaluating neuropsychological endophenotypes for attention-dencit/hyperactivity disorder. Biol Psychiatry 57:1347-1356.
53. Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K. 2006. The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Affect Behav Neurosci 6:18-30.
54. Wechsler D, Psychological Corporation. 1991. WISC-III: Wechsler Intelligence Scale for Children: Manual. San Antonio: Psychological Corp.
55. Weinshilboum RM. 1978. Serum dopamine beta-hydroxylase. Pharmacol Rev 30:133-166.
56. Wigg K, Zai G, Schachar R, et al. 2002. Attention deficit hyperactivity disorder and the gene for dopamine-beta-hydroxylase. Am J Psychiatry 159:1046-1048.
57. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attention-dencit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry 57:1336-1346.
58. Zabetian CP, Anderson GM, Buxbaum SG, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515-522.
59. Zhang HB, Wang YF, Li J, Wang B, Yang L. 2004. Association of dopamine beta-hydroxylase polymorphism with attention deficit hyperactivity disorder in children. Beijing Da Xue Xue Bao 36:290-293.
60. Zhang HB, Wang YF, Li J, Wang B, Yang L. 2005. Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder. Zhonghua Er Ke Za Zhi 43:26-30.